Netherlands· NL-02e49fb5a539
Cymevene 500 mg, poeder voor concentraat voor oplossing voor infusie
A ganciclovir product containing ganciclovir natrium, registered in Netherlands by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ganciclovir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AB06 (ganciclovir), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Ganciclovir · ATC J05AB06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ganciclovir costs, country by country.
Normalised to the WHO defined daily dose (3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ganciclovir · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$494.50
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- GANCICLOVIR NATRIUM
- Manufacturer
- CHEPLAPHARM Arzneimittel GmbH
- Country
- Netherlands (NL)
- ATC code
- J05AB06
- ATC class
- Ganciclovir
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id13007
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
277 interactions on record for ganciclovir.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ganciclovir · interactions on record
277 records
- 8 severe
- 194 moderate
- 75 info
Most severe, free to view
- CladribineL01BB04severe
- TrospiumA03AB20moderate
- Amphotericin BA07AA07moderate
- NitisinoneA16AX04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ganciclovir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCymeveneCheplapharm Arzneimittel GmbH
- SwedenCymevene 500 mg Pulver till koncentrat till infusionsvätska, lösningCheplapharm Arzneimittel GmbH
- PolandCymeveneInPharm Sp. z o.o.
- United KingdomCymevene 500mg powder for concentrate for solution for infusion vialsNeon Healthcare Ltd
- SpainCYMEVENE 500 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONCheplapharm Arzneimittel Gmbh
- NorwayCymeveneCheplapharm Arzneimittel GmbH
- CzechiaCYMEVENECHEPLAPHARM Arzneimittel GmbH, Greifswald
- BelgiumCymevene 500 mgCheplapharm Arzneimittel
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Cymevene, Ganciclovir Oresund Pharma
- Belgium · Cymevene, Virgan
- Bulgaria · Ганцикловир Ромфарм
- Czechia · Cymevene, Virgan
- Germany · Cymeven I.V., Ganciclovir Accord
- Denmark · Cymevene, Ganciclovir Oresund Pharma
- Spain · Cymevene, Ganciclovir Accord
- Finland · Cymevene, Ganciclovir Bioglan
- France · Cymevan, Ganciclovir Hikma
- United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
- Greece · Gancilen, Virgan
- Croatia · Cymevene
- Hungary · Cymevene, Ganciclovir Rompharm
- Ireland · Cymevene
- Italy · Citovirax, Ganciclovir Accord
- Luxembourg · Cymevene, Virgan
- Norway · Cymevene, Ganciclovir Bioglan
- Poland · Cymevene, Ganciclovir Accord
- Portugal · Cymevene, Ganciclovir Accord
- Romania · Ganciclovir Rompharm, Virgan
- Sweden · Cymevene, Ganciclovir Bioglan
- Slovakia · Cymevene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/227446da-97ae-49ac-b37f-03dc05128ba7 GET /v1/drugs/227446da-97ae-49ac-b37f-03dc05128ba7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor oplossing voor infusie",
"route": null,
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h13007_smpc.pdf",
"strength": null,
"atc_label": "Ganciclovir",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg13007",
"excipients": [
"NATRIUMHYDROXIDE (E 524)",
"ZOUTZUUR (E 507)"
],
"substances": [
"GANCICLOVIR NATRIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h13007.pdf",
"authorised_at": "1988/10/25",
"procedure_number": "NL/H/3775/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "13007",
"additional_monitoring": "N"
}See everything about ganciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.